Form 4 for LFST LifeStance Health Group, Inc.
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-05 · accession 0001193125-26-099064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-05 | LFST | Bourdon David | CEO, Dir | A - Grant | $0.00 | +395.7K | 1.28M | +45% | $0 | |
| 2026-03-09 | 2026-03-06 | LFST | Bourdon David | CEO, Dir | F - Tax | $6.93 | -65.8K | 1.22M | -5% | -$456.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | A | A | 395,683 | $0.00 | 1,283,922 | D | — | — | (F1) Includes 395,683 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-06 | F | D | 65,837 | $6.93 | 1,218,085 | D | — | — |